Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 25101120 |
US |
||
Tremor, Gait disturbance, Pruritus, Mouth haemorrhage, Candida infection, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 802 | 25101126 |
IT |
54 | 1 |
Pruritus, Erythema, Conjunctival hyperaemia, Dyspnoea, Oxygen saturation decreased, |
||||
NIVOLUMAB, OXALIPLATIN, |
||||
| 803 | 25101137 |
US |
||
Pruritus, Drug ineffective, Malaise, Fatigue, Headache, Impaired driving ability, Treatment noncompliance, Intentional product misuse, Product quality issue, Product physical consistency issue, Product odour abnormal, Liquid product physical issue, Product label issue, Injection site erythema, Injection site pain, Injection site swelling, Condition aggravated, |
||||
TESTOSTERONE, TESTOSTERONE,, TESTOSTERONE, TESTOSTERONE,, TESTOSTERONE, TESTOSTERONE,, |
||||
| 804 | 25101197 |
US |
2 | |
Rash, Erythema, Eye swelling, Pruritus, Therapy change, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 805 | 25101204 |
CA |
2 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pulmonary fibrosis, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Seronegative arthritis, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Tachycardia, Systemic lupus erythematosus, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Dyspnoea, |
||||
ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, AZATHIOPRINE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
| 806 | 25101248 |
US |
2 | |
Pruritus, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 807 | 25101259 |
CA |
31 | 2 |
Skin exfoliation, Product administered at inappropriate site, Withdrawal syndrome, Pruritus, Staphylococcal skin infection, Erythema, Skin weeping, |
||||
| 808 | 25101301 |
|||
Dyspnoea, Pruritus, Swollen tongue, Lip swelling, Respiratory distress, Drug hypersensitivity, Anaphylactic reaction, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 809 | 25101360 |
US |
||
Death, Thrombocytopenia, Neutropenia, Leukopenia, Anaemia, Lymphopenia, Hyperglycaemia, Fatigue, Back pain, Hypocalcaemia, Infusion related reaction, Hypoalbuminaemia, Hyponatraemia, Aspartate aminotransferase increased, Dyspnoea, Headache, Hypophosphataemia, Pyrexia, Pneumonia, Pruritus, Hypertension, Plasma cell myeloma, Encephalopathy, Infection, Sinusitis, Hyperuricaemia, Therapy partial responder, Epistaxis, Chills, Therapy non-responder, Haemorrhage, Diarrhoea, Tachycardia, Nausea, Cough, Wheezing, |
||||
CARFILZOMIB, FILGRASTIM, DARATUMUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, |
||||
| 810 | 25101431 |
US |
64 | 1 |
Rash macular, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 811 | 25101610 |
US |
2 | |
Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 812 | 25101612 |
US |
9 | 2 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 813 | 25101719 |
US |
55 | 2 |
Dermatitis, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 814 | 25101807 |
US |
22 | 1 |
Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 815 | 25101808 |
US |
64 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 816 | 25101863 |
US |
44 | 1 |
Pruritus, Blood cholesterol increased, |
||||
DOLUTEGRAVIR SODIUM AND LAMIVUDINE, |
||||
| 817 | 25101874 |
VN |
30 | 2 |
Stevens-Johnson syndrome, Pruritus, Rash, Off label use, |
||||
OXCARBAZEPINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 818 | 25102045 |
US |
1 | |
Pruritus, |
||||
AMIVANTAMAB, OSIMERTINIB, |
||||
| 819 | 25102051 |
US |
25 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 820 | 25102352 |
US |
2 | |
Pruritus, |
||||
OCRELIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METHYLPREDNISOLONE SODIUM SUCCINATE, GABAPENTIN, |
||||
| 821 | 25102400 |
CA |
44 | 2 |
Injury, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sciatica, Sleep disorder due to a general medical condition, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight fluctuation, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, LEFLUNOMIDE, MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RITUXIMAB, RITUXIMAB, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERYTHROMYCIN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, MELOXICAM, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LANSOPRAZOLE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, ALBUTEROL SULFATE, ALBUTEROL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, LISINOPRIL, SECUKINUMAB, |
||||
| 822 | 25102408 |
US |
65 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 823 | 25105243 |
52 | 2 | |
Pruritus, |
||||
TIRZEPATIDE, |
||||
| 824 | 25105834 |
75 | 1 | |
Pruritus, |
||||
CLOPIDOGREL BISULFATE, |
||||
| 825 | 25106290 |
78 | 1 | |
Angioedema, Rash, Pruritus, |
||||
LISINOPRIL, |
||||
| 826 | 25106356 |
63 | 1 | |
Drug hypersensitivity, Pruritus, Rash, Rash, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 827 | 25092165 |
US |
2 | |
Pruritus, Therapeutic response shortened, Inflammation, Condition aggravated, Injection site swelling, Product use in unapproved indication, |
||||
DUPILUMAB, ONABOTULINUMTOXINA, |
||||
| 828 | 25092170 |
US |
71 | 2 |
Pruritus, Off label use, Allergy to animal, |
||||
LINACLOTIDE, |
||||
| 829 | 25092174 |
US |
86 | 2 |
Pruritus, Dry skin, Injection site pain, Dry eye, |
||||
DUPILUMAB, |
||||
| 830 | 25092187 |
US |
37 | 2 |
Pruritus, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 831 | 25092208 |
CA |
2 | |
Pulmonary fibrosis, Wound infection, Pustular psoriasis, Weight increased, Pericarditis, Type 2 diabetes mellitus, Peripheral swelling, Systemic lupus erythematosus, Rash vesicular, Sleep disorder, Rheumatoid arthritis, Synovitis, Pruritus, Swollen joint count increased, Rheumatic fever, Psoriasis, Rash, Subcutaneous drug absorption impaired, Weight decreased, Wheezing, Pneumonia, Swelling, X-ray abnormal, Pemphigus, Sleep disorder due to general medical condition, insomnia type, Pyrexia, Sinusitis, Rheumatoid factor positive, Urticaria, Stomatitis, Wound, Psoriatic arthropathy, Vomiting, |
||||
DICLOFENAC SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LANSOPRAZOLE, CALCIUM GLUCONATE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LISINOPRIL, LORAZEPAM, SECUKINUMAB, RAMIPRIL, OXYCODONE, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOGESTREL AND ETHINYL ESTRADIOL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 832 | 25092218 |
US |
2 | |
Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 833 | 25092394 |
US |
2 | |
Nasal congestion, Rhinorrhoea, Peripheral swelling, Pruritus, Dry throat, Aphonia, Insomnia, Dry skin, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FAMOTIDINE, CALCIUM, |
||||
| 834 | 25092453 |
CA |
||
Infection, Back pain, Muscle spasms, Nasopharyngitis, Headache, Cough, Pruritus, Dyspnoea, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 835 | 25092468 |
US |
2 | |
Fatigue, Pruritus, Off label use, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, AMLODIPINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LEVOTHYROXINE, LOSARTAN POTASSIUM, LOSARTAN, ROSUVASTATIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIZANIDINE HYDROCHLORIDE, |
||||
| 836 | 25092473 |
US |
1 | |
Generalised oedema, Erythema, Pruritus, |
||||
DUPILUMAB, METHYLPREDNISOLONE, |
||||
| 837 | 25092478 |
US |
50 | 2 |
Pruritus, Pain of skin, Condition aggravated, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 838 | 25092482 |
GR |
77 | 2 |
Mouth swelling, Drug hypersensitivity, Erythema, Off label use, Pruritus, Chest discomfort, Asthma, Oropharyngeal swelling, Gingival erythema, Muscle spasms, Allergic oedema, Swelling, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, IRBESARTAN, METOPROLOL TARTRATE, |
||||
| 839 | 25092498 |
US |
39 | 1 |
Pruritus, Condition aggravated, Injection site reaction, Eczema, |
||||
DUPILUMAB, |
||||
| 840 | 25092540 |
US |
52 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 841 | 25092556 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, |
||||
| 842 | 25092558 |
US |
28 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 843 | 25092571 |
US |
2 | |
Oropharyngeal pain, Erythema, Pruritus, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 844 | 25092583 |
US |
1 | |
Product dose omission issue, Skin disorder, Malaise, Alopecia, Skin atrophy, Pruritus, Weight decreased, Dry skin, Joint swelling, Rash, Exercise tolerance decreased, |
||||
RIVAROXABAN, |
||||
| 845 | 25092596 |
US |
74 | 2 |
Eye swelling, Intraocular lens implant, Glaucoma drainage device placement, Pruritus, Eye operation, Eye irritation, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 846 | 25092700 |
US |
41 | 2 |
Multiple allergies, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 847 | 25092708 |
US |
2 | |
Supraventricular tachycardia, Palpitations, Dysphonia, Dry skin, Rash, Inflammation, Nausea, Pruritus, Injection site pain, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 848 | 25092730 |
US |
50 | 2 |
Pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 849 | 25092732 |
US |
3 | 1 |
Pruritus, Middle insomnia, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 850 | 25092857 |
CA |
22 | 2 |
Cough, Dysphagia, Heart rate increased, Nausea, Throat irritation, Throat tightness, Anaphylactic reaction, Pruritus, Dyspnoea, |
||||
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, |
||||
| 851 | 25092890 |
US |
51 | 2 |
Infusion site erythema, Infusion site swelling, Flushing, Pruritus, |
||||
| 852 | 25093188 |
CA |
2 | |
Liver injury, General symptom, Headache, General physical health deterioration, Infection, Hypoaesthesia, Ill-defined disorder, Hypertension, Helicobacter infection, Hypersensitivity, Hypercholesterolaemia, Impaired healing, Hand deformity, Injury, Glossodynia, Grip strength decreased, Infusion related reaction, Hepatic enzyme increased, Sinusitis, Urticaria, Sleep disorder due to general medical condition, insomnia type, Adjustment disorder with depressed mood, Pemphigus, Wheezing, Psoriatic arthropathy, Joint range of motion decreased, Abdominal pain upper, Subcutaneous drug absorption impaired, Contusion, Psoriasis, Myositis, Pneumonia, Pain in extremity, Systemic lupus erythematosus, Pulmonary fibrosis, Vomiting, Blister, Wound infection, Swelling, Oedema, Rash, Chest pain, Lower respiratory tract infection, Amnesia, Migraine, Back disorder, Pruritus, Stomatitis, Memory impairment, Mobility decreased, Decreased appetite, Rheumatic fever, Muscle injury, X-ray abnormal, Weight increased, Swollen joint count increased, Sleep disorder, Type 2 diabetes mellitus, Synovitis, Breast cancer stage II, Wound, Weight decreased, Malaise, Rheumatoid arthritis, Joint swelling, Irritable bowel syndrome, Rash vesicular, Peripheral swelling, Pericarditis, Pustular psoriasis, Pyrexia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, USTEKINUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CAFFEINE CITRATE, CAFFEINE CITRATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN, NAPROXEN SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, RAMIPRIL, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, SARILUMAB, QUETIAPINE FUMARATE, QUETIAPINE, VEDOLIZUMAB, VEDOLIZUMAB, LORAZEPAM, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREDNISONE, SECUKINUMAB, SECUKINUMAB, CALCIUM CARBONATE, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LANSOPRAZOLE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, VITAMIN C, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN AND CAFFEINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 853 | 25093321 |
US |
1 | |
Cholangitis sclerosing, Abdominal pain upper, Diarrhoea, Anxiety, Arthralgia, Pruritus, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 854 | 25093327 |
14 | 2 | |
Eye swelling, Pruritus, Erythema, |
||||
CLINDAMYCIN AND BENZOYL PEROXIDE, |
||||
| 855 | 25093335 |
US |
73 | 2 |
Pruritus, Skin exfoliation, |
||||
TRALOKINUMAB-LDRM, |
||||
| 856 | 25093367 |
US |
||
Pruritus, |
||||
TIRZEPATIDE, |
||||
| 857 | 25093488 |
US |
77 | 1 |
Pruritus, |
||||
LENALIDOMIDE, |
||||
| 858 | 25093655 |
CN |
64 | 2 |
Pruritus, Throat tightness, Larynx irritation, Tremor, Laryngeal pain, Blood pressure increased, Heart rate increased, |
||||
RITUXIMAB, |
||||
| 859 | 25093721 |
US |
53 | 1 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 860 | 25093725 |
US |
82 | 2 |
Pruritus, Paraesthesia oral, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 861 | 25093727 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, |
||||
| 862 | 25093755 |
US |
2 | |
Skin disorder, Skin haemorrhage, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 863 | 25093757 |
US |
60 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 864 | 25093761 |
US |
67 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 865 | 25093768 |
US |
33 | 2 |
Condition aggravated, Pruritus, Papule, |
||||
DUPILUMAB, |
||||
| 866 | 25093779 |
US |
89 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 867 | 25093781 |
US |
2 | 2 |
Pruritus, Therapeutic response shortened, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 868 | 25093784 |
US |
53 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 869 | 25093814 |
US |
44 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Rash, Product use in unapproved indication, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 870 | 25093838 |
US |
46 | 2 |
Pruritus, |
||||
LENALIDOMIDE, |
||||
| 871 | 25093919 |
US |
24 | 2 |
Anaphylactic reaction, Hypoaesthesia oral, Paraesthesia oral, Dysphagia, Pruritus, Lip swelling, Dyspnoea, |
||||
OMALIZUMAB, PYRIDOSTIGMINE BROMIDE, LISDEXAMFETAMINE DIMESYLATE, DIPHENHYDRAMINE HYDROCHLORIDE, IVABRADINE, KETOTIFEN FUMARATE, CROMOLYN SODIUM, MODAFINIL, MONTELUKAST SODIUM, DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, DESVENLAFAXINE SUCCINATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE, IRON, MAGNESIUM, FAMOTIDINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 872 | 25093950 |
FI |
74 | 1 |
Night blindness, Dry eye, Nasal dryness, Dry mouth, Thirst, Chapped lips, Blood cholesterol increased, Pruritus, Cataract, |
||||
HYDROCORTISONE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, |
||||
| 873 | 25093975 |
US |
2 | |
Discomfort, Sleep disorder, Pruritus, Rash, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FAMOTIDINE, |
||||
| 874 | 25093998 |
US |
72 | 2 |
Psoriasis, Pain, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 875 | 25094012 |
US |
36 | 2 |
Neurodermatitis, Skin infection, Skin hyperpigmentation, Formication, Pruritus, |
||||
DUPILUMAB, |
||||
| 876 | 25094025 |
US |
3 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 877 | 25094058 |
US |
62 | 1 |
Chest discomfort, Sleep disorder due to general medical condition, insomnia type, Blister, Acne, Headache, Rash, Pruritus, Abdominal distension, Constipation, Nausea, Abdominal pain upper, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 878 | 25094087 |
US |
82 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 879 | 25094089 |
US |
49 | 2 |
Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 880 | 25094095 |
US |
41 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 881 | 25094101 |
US |
29 | 2 |
Rash erythematous, Burning sensation, Pruritus, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 882 | 25094102 |
US |
19 | 2 |
Haemorrhage, Erythema, Condition aggravated, Dry skin, Dry eye, Pruritus, Eye pruritus, Ocular hyperaemia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 883 | 25094106 |
US |
16 | 1 |
Rash macular, Lip swelling, Skin exfoliation, Erythema, Skin burning sensation, Pruritus, |
||||
DUPILUMAB, PREDNISONE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 884 | 25094138 |
CA |
97 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 885 | 25094159 |
US |
52 | 2 |
Skin burning sensation, Rash, Pruritus, |
||||
NALTREXONE, |
||||
| 886 | 25094355 |
US |
2 | |
Hallucination, Flushing, Abdominal pain, Pruritus, |
||||
DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
| 887 | 25094452 |
US |
70 | 1 |
Erythema, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 888 | 25094610 |
US |
49 | 2 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 889 | 25094718 |
MX |
50 | 1 |
Skin lesion, Product use in unapproved indication, Pruritus, Hypersensitivity, Skin swelling, Scratch, Erythema, |
||||
LENALIDOMIDE, RITUXIMAB, |
||||
| 890 | 25094776 |
US |
87 | 2 |
Injection site pain, Skin swelling, Pruritus, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DONEPEZIL HYDROCHLORIDE, APIXABAN, GABAPENTIN, LEVOTHYROXINE, MODAFINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PYRIDOSTIGMINE BROMIDE ORAL, |
||||
| 891 | 25094917 |
US |
46 | 1 |
Skin disorder, Condition aggravated, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 892 | 25094956 |
US |
49 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 893 | 25094957 |
US |
80 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 894 | 25094958 |
US |
40 | 2 |
Rash macular, Pruritus, |
||||
DUPILUMAB, |
||||
| 895 | 25094985 |
US |
62 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 896 | 25095036 |
JP |
75 | 2 |
Hyperkalaemia, Hot flush, Eosinophil count increased, Pruritus, Taste disorder, |
||||
ISAVUCONAZONIUM SULFATE, |
||||
| 897 | 25095067 |
US |
65 | 2 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 898 | 25095072 |
US |
65 | 2 |
Lacrimation increased, Abnormal sensation in eye, Sleep disorder due to a general medical condition, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 899 | 25095077 |
US |
54 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 900 | 25095082 |
US |
65 | 1 |
Psoriasis, Pruritus, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28